Planning the New Normal

Date: May 13, 2020

 

From: 5:00 pm To: 6:30 pm (EST)

“During these difficult and unforeseen times, it is vital that we take action when it comes to planning for the ‘New Normal’. When restrictions are partially lifted, our aim as a translational research community will be to provide momentum for innovation for the future.

What should be done first? How does one restart a translational research agenda? How does one maneuver within the new system? Which priorities; data collection, grant writing, journal publishing, should come first? What are the implications for trials, licencing, approvals in this ‘New Normal’?

Join key opinion leaders as we brainstorm and discuss strategies to start unravelling what will need to be done to find a new balance.”

Register

Meredith Irwin

Panelist

The Hospital for Sick Children
Paediatrician-in-Chief
Paediatrics

Research Institute
Senior Scientist
Cell Biology

University of Toronto
Professor
Departments of Paediatrics, Medical Biophysics and Laboratory Medicine & Pathobiology

Laszlo Radvanyi

Panelist

President and Scientific Director
Ontario Institute of Cancer Research

Michael Farkouh

Panelist

Clinician Scientist, Toronto General Hospital Research Institute (TGHRI)

Aaron Schimmer

Panelist

Senior Scientist, Princess Margaret Cancer Centre
Director, Research Institute, Princess Margaret Cancer Centre

Norman Rosenblum

Moderator

The Hospital for Sick Children
Staff Nephrologist
Nephrology

Research Institute
Senior Scientist
Developmental & Stem Cell Biology

University of Toronto
Professor
Depts. of Paediatrics, Physiology, Laboratory Medicine & Pathobiology